GHK-Cu is a copper-binding tripeptide the body produces on its own, and it activates more than 4,000 repair genes, including the ones behind collagen and elastin synthesis. Plasma levels fall about 90% between age 20 and 60, which is exactly why aging-skin and connective-tissue research keeps circling back to it.
- Activates over 4,000 repair genes, including those for collagen and elastin synthesis.PubMed (GHK-Cu)
- Plasma levels decline roughly 90% between age 20 and 60, making it a natural target for aging research.PubMed (GHK-Cu)
- Gene activity spans collagen and elastin synthesis, angiogenesis, and anti-inflammatory signaling.PubMed (GHK-Cu)
- Honest limit: the human evidence is topical and skin-focused, with no systemic-injection trial behind it.researchdosing
- Copper peptides add copper, so extended work tracks the copper-to-zinc balance.peptidedosages